SK279997B6 - 2,4,8-trisubstituované-4,5-dihydro-5-oxo-3h,6h-1,4 - Google Patents

2,4,8-trisubstituované-4,5-dihydro-5-oxo-3h,6h-1,4 Download PDF

Info

Publication number
SK279997B6
SK279997B6 SK419-91A SK41991A SK279997B6 SK 279997 B6 SK279997 B6 SK 279997B6 SK 41991 A SK41991 A SK 41991A SK 279997 B6 SK279997 B6 SK 279997B6
Authority
SK
Slovakia
Prior art keywords
alkyl
dihydro
formula
trifluoromethyl
compound
Prior art date
Application number
SK419-91A
Other languages
English (en)
Slovak (sk)
Inventor
Shin Shyong Tseng
Joseph W. Epstein
Jeremy I. Levin
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of SK279997B6 publication Critical patent/SK279997B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK419-91A 1990-02-21 1991-02-19 2,4,8-trisubstituované-4,5-dihydro-5-oxo-3h,6h-1,4 SK279997B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/482,568 US5013737A (en) 1988-02-22 1990-02-21 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones

Publications (1)

Publication Number Publication Date
SK279997B6 true SK279997B6 (sk) 1999-06-11

Family

ID=23916572

Family Applications (1)

Application Number Title Priority Date Filing Date
SK419-91A SK279997B6 (sk) 1990-02-21 1991-02-19 2,4,8-trisubstituované-4,5-dihydro-5-oxo-3h,6h-1,4

Country Status (24)

Country Link
US (1) US5013737A (pt)
EP (1) EP0443312B1 (pt)
JP (1) JP3046851B2 (pt)
KR (1) KR0183395B1 (pt)
AT (1) ATE152723T1 (pt)
AU (1) AU640202B2 (pt)
CA (1) CA2036589A1 (pt)
CZ (1) CZ285584B6 (pt)
DE (1) DE69125962T2 (pt)
DK (1) DK0443312T3 (pt)
ES (1) ES2102371T3 (pt)
FI (1) FI93963C (pt)
GR (1) GR3024063T3 (pt)
HU (1) HUT60500A (pt)
IE (1) IE910575A1 (pt)
IL (1) IL97289A (pt)
NO (1) NO177749C (pt)
NZ (1) NZ237123A (pt)
PH (1) PH27464A (pt)
PL (1) PL166100B1 (pt)
PT (1) PT96805B (pt)
SG (1) SG47638A1 (pt)
SK (1) SK279997B6 (pt)
ZA (1) ZA911260B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1129091E (pt) * 1998-11-12 2003-02-28 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos relacionados
CN1178941C (zh) * 1998-11-12 2004-12-08 纽罗克里恩生物科学有限公司 Crf受体拮抗剂以及与其有关的方法
CA2643968A1 (en) * 2006-03-17 2007-09-27 Wyeth Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
US20070219183A1 (en) * 2006-03-17 2007-09-20 Wyeth Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof
KR200480580Y1 (ko) * 2015-09-30 2016-06-13 김영직 어린이용 우산

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178449A (en) * 1978-04-17 1979-12-11 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4614732A (en) * 1984-10-26 1986-09-30 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
ATE99686T1 (de) * 1988-02-22 1994-01-15 American Cyanamid Co 5-(substituierte amino)-8-(phenyl oder substituierte phenyl)-3h,6h-1,4,5a,8atetraazaacenaphthylen-3-one.

Also Published As

Publication number Publication date
NO910686L (no) 1991-08-22
EP0443312A3 (en) 1992-02-19
DE69125962T2 (de) 1997-10-16
FI910816A (fi) 1991-08-22
IL97289A0 (en) 1992-05-25
CZ285584B6 (cs) 1999-09-15
DE69125962D1 (de) 1997-06-12
US5013737A (en) 1991-05-07
HUT60500A (en) 1992-09-28
PL289157A1 (en) 1992-06-26
EP0443312A2 (en) 1991-08-28
PT96805B (pt) 1998-07-31
AU640202B2 (en) 1993-08-19
ATE152723T1 (de) 1997-05-15
NO177749C (no) 1995-11-15
FI910816A0 (fi) 1991-02-20
PL166100B1 (pl) 1995-03-31
EP0443312B1 (en) 1997-05-07
HU910584D0 (en) 1991-09-30
DK0443312T3 (da) 1997-11-17
FI93963C (fi) 1995-06-26
ZA911260B (en) 1992-10-28
PH27464A (en) 1993-07-09
CS41991A3 (en) 1991-09-15
AU7122591A (en) 1991-08-22
NO177749B (no) 1995-08-07
SG47638A1 (en) 1998-04-17
JPH04211086A (ja) 1992-08-03
NZ237123A (en) 1994-07-26
IL97289A (en) 1995-06-29
NO910686D0 (no) 1991-02-20
ES2102371T3 (es) 1997-08-01
GR3024063T3 (en) 1997-10-31
KR0183395B1 (ko) 1999-05-01
JP3046851B2 (ja) 2000-05-29
PT96805A (pt) 1991-10-31
CA2036589A1 (en) 1991-08-22
FI93963B (fi) 1995-03-15
IE910575A1 (en) 1991-08-28

Similar Documents

Publication Publication Date Title
US5736549A (en) Hypoxanthine and guanine compounds
WO1998014451A1 (en) Fused pyrazole derivative and process for its preparation
JP2003533453A (ja) ホスホジエステラーゼ阻害剤として有効なβ−カルボリン誘導体
AU2009276420A1 (en) Piperidine derivatives as JAK3 inhibitors
EP2576561A1 (en) Heterocyclic compounds as janus kinase inhibitors
EP0460116B1 (en) 9-substituted-8-unsubstituted-9-deazaguanines
AU5704199A (en) 5-heterocyclyl pyrazolo(4,3-d)pyrimidin-7-ones for the treatment of male erectile dysfunction
EP0880524A1 (de) Neue triazolopurine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SK279997B6 (sk) 2,4,8-trisubstituované-4,5-dihydro-5-oxo-3h,6h-1,4
US4705793A (en) Pyrazolo[3,4-b]pyrrolo[3,4-e]pyridine-5(1H)-one and 1-H-pyrazolo[3,4-b][1,6]naphthyridine-5(6H)-one derivations, useful as anti-anxiety agents
EP3915990A1 (en) 4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-3,6-dihydropyridine-1-(2h)-carboxamide derivatives as limk and/or rock kinases inhibitors for use in the treatment of cancer
US4916137A (en) 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders
US3573324A (en) 2,3,4,5,10,10a-hexahydroazepino(2,3-b)indoles
EP0329940B1 (en) 5-(substituted)amino)-8- (phenyl or substituted phenyl)-3H,6H-1,2,5,a,8 a-tetraazaacenaphthylen-3-ones
AU613259B2 (en) 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
FR2640975A1 (pt)